vs
Paymentus Holdings, Inc.（PAY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Paymentus Holdings, Inc.的1.9倍（$622.0M vs $330.5M），Royalty Pharma plc净利率更高（34.4% vs 6.3%，领先28.2%），Paymentus Holdings, Inc.同比增速更快（28.1% vs 4.8%），过去两年Paymentus Holdings, Inc.的营收复合增速更高（33.7% vs 4.6%）
Paymentus Holdings, Inc.是领先的云原生账单支付与客户互动技术服务商，面向公用事业、金融服务、政府、医疗、电信等领域企业提供集成数字支付解决方案、账单自动化工具和自助服务门户，核心业务覆盖北美市场。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PAY vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$330.5M
营收增速更快
PAY
高出23.4%
4.8%
净利率更高
RPRX
高出28.2%
6.3%
两年增速更快
PAY
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $330.5M | $622.0M |
| 净利润 | $20.7M | $214.2M |
| 毛利率 | 25.4% | — |
| 营业利润率 | 7.3% | 62.4% |
| 净利率 | 6.3% | 34.4% |
| 营收同比 | 28.1% | 4.8% |
| 净利润同比 | 57.2% | 2.9% |
| 每股收益（稀释后） | $0.16 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PAYRPRX
| Q4 25 | $330.5M | $622.0M | ||
| Q3 25 | $310.7M | $609.3M | ||
| Q2 25 | $280.1M | $578.7M | ||
| Q1 25 | $275.2M | $568.2M | ||
| Q4 24 | $257.9M | $593.6M | ||
| Q3 24 | $231.6M | $564.7M | ||
| Q2 24 | $197.4M | $537.3M | ||
| Q1 24 | $184.9M | $568.0M |
净利润PAYRPRX
| Q4 25 | $20.7M | $214.2M | ||
| Q3 25 | $17.7M | $288.2M | ||
| Q2 25 | $14.7M | $30.2M | ||
| Q1 25 | $13.8M | $238.3M | ||
| Q4 24 | $13.1M | $208.2M | ||
| Q3 24 | $14.4M | $544.0M | ||
| Q2 24 | $9.4M | $102.0M | ||
| Q1 24 | $7.2M | $4.8M |
毛利率PAYRPRX
| Q4 25 | 25.4% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 25.5% | — | ||
| Q1 25 | 24.0% | — | ||
| Q4 24 | 25.6% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 29.8% | — | ||
| Q1 24 | 28.5% | — |
营业利润率PAYRPRX
| Q4 25 | 7.3% | 62.4% | ||
| Q3 25 | 6.4% | 70.1% | ||
| Q2 25 | 5.7% | 36.3% | ||
| Q1 25 | 5.7% | 94.0% | ||
| Q4 24 | 5.5% | 60.9% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | 5.2% | 50.2% | ||
| Q1 24 | 4.5% | -13.0% |
净利率PAYRPRX
| Q4 25 | 6.3% | 34.4% | ||
| Q3 25 | 5.7% | 47.3% | ||
| Q2 25 | 5.3% | 5.2% | ||
| Q1 25 | 5.0% | 41.9% | ||
| Q4 24 | 5.1% | 35.1% | ||
| Q3 24 | 6.2% | 96.3% | ||
| Q2 24 | 4.7% | 19.0% | ||
| Q1 24 | 3.9% | 0.8% |
每股收益（稀释后）PAYRPRX
| Q4 25 | $0.16 | $0.49 | ||
| Q3 25 | $0.14 | $0.67 | ||
| Q2 25 | $0.11 | $0.07 | ||
| Q1 25 | $0.11 | $0.55 | ||
| Q4 24 | $0.11 | $0.46 | ||
| Q3 24 | $0.11 | $1.21 | ||
| Q2 24 | $0.07 | $0.23 | ||
| Q1 24 | $0.06 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $320.9M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $560.4M | $9.7B |
| 总资产 | $667.9M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PAYRPRX
| Q4 25 | $320.9M | $618.7M | ||
| Q3 25 | $287.9M | $938.9M | ||
| Q2 25 | $266.4M | $631.9M | ||
| Q1 25 | $245.8M | $1.1B | ||
| Q4 24 | $205.9M | $929.0M | ||
| Q3 24 | $187.5M | $950.1M | ||
| Q2 24 | $188.8M | $1.8B | ||
| Q1 24 | $180.1M | $843.0M |
总债务PAYRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益PAYRPRX
| Q4 25 | $560.4M | $9.7B | ||
| Q3 25 | $537.4M | $9.6B | ||
| Q2 25 | $516.7M | $9.5B | ||
| Q1 25 | $500.4M | $9.8B | ||
| Q4 24 | $485.6M | $10.3B | ||
| Q3 24 | $468.8M | $10.3B | ||
| Q2 24 | $451.6M | $9.8B | ||
| Q1 24 | $439.4M | $9.9B |
总资产PAYRPRX
| Q4 25 | $667.9M | $19.6B | ||
| Q3 25 | $644.4M | $19.3B | ||
| Q2 25 | $609.5M | $18.3B | ||
| Q1 25 | $590.9M | $17.6B | ||
| Q4 24 | $576.2M | $18.2B | ||
| Q3 24 | $552.9M | $18.0B | ||
| Q2 24 | $527.7M | $17.7B | ||
| Q1 24 | $514.0M | $16.1B |
负债/权益比PAYRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $45.0M | — |
| 自由现金流率自由现金流/营收 | 13.6% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 2.18× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $161.8M | — |
8季度趋势，按日历期对齐
经营现金流PAYRPRX
| Q4 25 | $45.1M | $827.1M | ||
| Q3 25 | $35.1M | $702.6M | ||
| Q2 25 | $31.5M | $364.0M | ||
| Q1 25 | $50.4M | $596.1M | ||
| Q4 24 | $27.9M | $742.5M | ||
| Q3 24 | $6.7M | $703.6M | ||
| Q2 24 | $18.0M | $658.2M | ||
| Q1 24 | $11.0M | $664.6M |
自由现金流PAYRPRX
| Q4 25 | $45.0M | — | ||
| Q3 25 | $35.0M | — | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $50.4M | — | ||
| Q4 24 | $27.8M | — | ||
| Q3 24 | $6.7M | — | ||
| Q2 24 | $17.8M | — | ||
| Q1 24 | $10.8M | — |
自由现金流率PAYRPRX
| Q4 25 | 13.6% | — | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 11.2% | — | ||
| Q1 25 | 18.3% | — | ||
| Q4 24 | 10.8% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 9.0% | — | ||
| Q1 24 | 5.9% | — |
资本支出强度PAYRPRX
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率PAYRPRX
| Q4 25 | 2.18× | 3.86× | ||
| Q3 25 | 1.98× | 2.44× | ||
| Q2 25 | 2.14× | 12.06× | ||
| Q1 25 | 3.65× | 2.50× | ||
| Q4 24 | 2.12× | 3.57× | ||
| Q3 24 | 0.47× | 1.29× | ||
| Q2 24 | 1.93× | 6.45× | ||
| Q1 24 | 1.52× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PAY
| Payment Transaction Processing Revenue | $326.9M | 99% |
| Other | $3.5M | 1% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
